Gammagard Liquid Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.
Condition:   RabiesInterventions:   Biological: rhRIG（20 IU/kg）;   Biological: rhRIG（40 IU/kg）;   Biological: HRIG（20 IU/kg）;   Biological: rhRIG（20 IU/kg） and vaccine;   Biological: rhRIG（40 IU/kg） and vaccine;   Biological: HRIG（20 IU/kg） and vaccine;   Biological: placebo and vaccineSponsor:   Beijing Chaoyang District Centre for Disease Control and PreventionEnrolling by invitation - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2015 Category: Research Source Type: clinical trials